Carclo plc's latest update points to one part of the group doing particularly well. The central question is how much the company is relying on aerospace Demand in its smaller Speciality division while its larger contract Manufacturing Business works through uneven volumes, and what that means for the rest of the financial year.
What Carclo does
Carclo (LSE:CAR) is a precision engineering group listed on the Main Market of the London Stock Exchange. Its largest operation is CTP, which provides contract manufacturing and design and engineering services, mostly precision plastic components for customers in areas such as life sciences diagnostics. The CTP business is split into Manufacturing Solutions and Design and Engineering. The Speciality division supplies the aerospace market. Its financial year ends on 31 March.
The September trading statement
On 9 September 2026, ahead of its annual general meeting, Carclo issued a trading statement covering the opening months of its 2027 financial year. The company said year-to-date Revenue was slightly behind the prior year, while underlying operating profit and return on sales were in line with its expectations. By division, it reported top-line growth with solid margins in EMEA Manufacturing Solutions, a recovery in US volumes in the second quarter after a slow first quarter, broadly flat revenue in Design and Engineering with better margins, and higher revenue and margins in Speciality, which it attributed to healthy aerospace demand.
The chief executive said margins, operating profit and return on sales were all ahead of last year on slightly lower revenue, with Speciality growing quickly on aerospace demand. The company kept its full-year expectations unchanged and said trading is expected to be weighted towards the second half.
Results that set the baseline
Carclo's audited results for the year to 31 March 2026, published on 1 July 2026, showed revenue of £114.2 million, down from £121.2 million. Underlying operating profit rose to £12.6 million from £9.8 million, and profit before tax increased to £4.8 million from £2.7 million. Return on sales reached 11.0% and return on Capital employed 29.1%, both above company targets.
The divisional split explains the aerospace emphasis. CTP revenue fell to £98.2 million, although its operating profit rose to £15.1 million. Speciality revenue increased 12.5% to £16.0 million, with operating profit of £3.6 million and an operating Margin of 22.4%. This suggests that, although Speciality is a modest share of sales, its margins give it a meaningful influence on group profit. No Dividend was proposed, with the board prioritising cash and Investment under its Precision 2030 plan, which targets organic revenue growth above 8% a year.
Balance sheet and risks
Year-end net Debt was £23.9 million, up from £19.2 million, which the company partly linked to a £5.1 million pension contribution. Cash fell to £5.8 million. The IAS 19 pension Liability improved to £46.8 million from £51.7 million but remains large relative to the business. In September, Carclo said net debt at the end of July was above the year-end level because of Lease extensions and Working Capital timing, though it expects net debt excluding leases to return to the year-end position by the end of the second quarter.
Other uncertainties include softer life sciences diagnostics demand, which the company previously tied to a weak respiratory season, and reliance on a second-half improvement to deliver full-year organic growth.
Conclusion
Carclo's September statement shows a group earning more from each pound of sales while revenue edges lower, with Speciality's aerospace work growing sharply. Full-year expectations were left unchanged. Interim results for the six months to 30 September 2026 are expected in November, and they should show whether the anticipated second-half weighting is beginning to come through.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...